User menu

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.

Bibliographic reference Hermine, Olivier ; Hoster, Eva ; Walewski, Jan ; Bosly, André ; Stilgenbauer, Stephan ; et. al. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.. In: The Lancet, Vol. 388, no.10044, p. 565-575 (2016)
Permanent URL http://hdl.handle.net/2078.1/176653